Providence Health and Services has been sued by a data analysis firm that claimed the 50-hospital system pushed its doctors to add complications or comorbidities to treatment documents so they could get higher Medicare reimbursement.
Oakland, Calif.-based Kaiser Permanente saw a 47% drop in operating income in the second quarter of 2018 compared with the prior-year period, despite reporting higher revenue.
St. Luke's University Health Network has created a new program that ensures patients with lower back pain get access to physical therapy within 48 hours to prevent chronic back pain that can lead to surgery and opioid dependency.
Centene Corp. and Ascension signed a letter of intent to research launching a joint Medicare Advantage plan. The companies hope to hit several insurance markets in 2020.
Kevin Fleming, Providence St. Joseph Health's vice president of orthopedics and sports medicine, talks about the organization's approach to managing physician preference items and savings earned through bundled payments.
John Starcher, CEO of Mercy Health, will lead the new organization with Bon Secours Health System after the merger closes, likely in the fall. Richard Statuto, longtime CEO of Bon Secours, will retire next year.
Not-for-profit health systems are finding clever ways to reduce or avoid the new tax law's 21% excise tax on executive compensation that exceeds $1 million.
The cost of paying for top talent at health systems climbs sharply above a million dollars thanks to recent tax legislation, and many of the largest system CEOs make more than that.
Total compensation paid to the leaders of the largest not-for-profit healthcare associations exceeded $1 million in at least 15 instances, according to IRS Form 990 tax filings for 2016.
Dallas-based Baylor Scott & White Health posted more profit in the first nine months of its fiscal 2018 than in its entire fiscal 2017.
While Geisinger will have to spend around $5 million upfront to bring DNA sequencing into routine clinical care, the health system's president and CEO, Dr. David Feinberg, said it won't cost patients anything and will ultimately save money.
Over the next six months, Geisinger will enroll 1,000 patients in a pilot program recommending DNA sequencing as part of routine clinical care. Eventually, the health system said it will provide clinical DNA sequencing across the board.